Macdonald Sean

SEC source: 0001062993-24-008115 · form4.xml · nonDerivative · entry 1

Macdonald Sean · CIK 0001553633 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 363,809

F1 · kind: On December 21, 2023, the Issuer's Board of Directors approved the award of 76,000 restricted shares of the Company's common stock to Mr. Macdonald, pursuant to a Restricted Stock Award Agreement, dated December 22, 2023, under the Company's 2011 Plan. On December 22, 2023, 2,875 of the restricted shares vested, an additional 7,500 will vest on December 22, 2024, another 13,125 restricted shares will vest on December 22, 2025, another 15,000 restricted shares will vest on December 22, 2026, another 18,750 restricted shares will vest on December 22, 2027, and the remaining 18,750 restricted shares will vest on December 22, 2028, provided, however, that one hundred percent (100%) of the Reporting Person's nonvested restricted stock will become fully vested in the event of a change of control. The Reporting Person is now the holder of 363,809 shares of the Issuer's common stock.

F1 · shares: On December 21, 2023, the Issuer's Board of Directors approved the award of 76,000 restricted shares of the Company's common stock to Mr. Macdonald, pursuant to a Restricted Stock Award Agreement, dated December 22, 2023, under the Company's 2011 Plan. On December 22, 2023, 2,875 of the restricted shares vested, an additional 7,500 will vest on December 22, 2024, another 13,125 restricted shares will vest on December 22, 2025, another 15,000 restricted shares will vest on December 22, 2026, another 18,750 restricted shares will vest on December 22, 2027, and the remaining 18,750 restricted shares will vest on December 22, 2028, provided, however, that one hundred percent (100%) of the Reporting Person's nonvested restricted stock will become fully vested in the event of a change of control. The Reporting Person is now the holder of 363,809 shares of the Issuer's common stock.

F1 · balance_after: On December 21, 2023, the Issuer's Board of Directors approved the award of 76,000 restricted shares of the Company's common stock to Mr. Macdonald, pursuant to a Restricted Stock Award Agreement, dated December 22, 2023, under the Company's 2011 Plan. On December 22, 2023, 2,875 of the restricted shares vested, an additional 7,500 will vest on December 22, 2024, another 13,125 restricted shares will vest on December 22, 2025, another 15,000 restricted shares will vest on December 22, 2026, another 18,750 restricted shares will vest on December 22, 2027, and the remaining 18,750 restricted shares will vest on December 22, 2028, provided, however, that one hundred percent (100%) of the Reporting Person's nonvested restricted stock will become fully vested in the event of a change of control. The Reporting Person is now the holder of 363,809 shares of the Issuer's common stock.

SEC source: 0001062993-23-008120 · form4.xml · nonDerivative · entry 3

Macdonald Sean · CIK 0001553633 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 287,809

F3 · kind: On December 20, 2022, the Issuer's Board approved the award of 10,000 restricted shares of the Issuer's common stock to the Reporting Person, pursuant to a Restricted Stock Award Agreement, under the Issuer's 2011 Plan, all of which vested on December 31, 2022. The Reporting Person is now the holder of 287,809 shares of the Issuer's common stock.

F3 · shares: On December 20, 2022, the Issuer's Board approved the award of 10,000 restricted shares of the Issuer's common stock to the Reporting Person, pursuant to a Restricted Stock Award Agreement, under the Issuer's 2011 Plan, all of which vested on December 31, 2022. The Reporting Person is now the holder of 287,809 shares of the Issuer's common stock.

F3 · balance_after: On December 20, 2022, the Issuer's Board approved the award of 10,000 restricted shares of the Issuer's common stock to the Reporting Person, pursuant to a Restricted Stock Award Agreement, under the Issuer's 2011 Plan, all of which vested on December 31, 2022. The Reporting Person is now the holder of 287,809 shares of the Issuer's common stock.

SEC source: 0001062993-23-008120 · form4.xml · nonDerivative · entry 2

Macdonald Sean · CIK 0001553633 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 277,809

F2 · kind: On February 25, 2019, the Issuer's Board of Directors approved a grant to the Reporting Person, of a ten-year option to purchase 78,000 shares of the Issuer's common stock at $2.30 per share under the 2011 Amended and Restated Equity Incentive Plan ("2011 Plan"), which vested in full on February 25, 2022. On December 13, 2022, the Reporting Person exercised his option to purchase these shares at an aggregate exercise price of $179,400. The purchase price was paid through a cashless transaction whereby the Issuer withheld 8,970 of the shares at the fair market value of $20 per share, in lieu of cash payment and the Reporting person received the remaining 69,030 shares.

F2 · shares: On February 25, 2019, the Issuer's Board of Directors approved a grant to the Reporting Person, of a ten-year option to purchase 78,000 shares of the Issuer's common stock at $2.30 per share under the 2011 Amended and Restated Equity Incentive Plan ("2011 Plan"), which vested in full on February 25, 2022. On December 13, 2022, the Reporting Person exercised his option to purchase these shares at an aggregate exercise price of $179,400. The purchase price was paid through a cashless transaction whereby the Issuer withheld 8,970 of the shares at the fair market value of $20 per share, in lieu of cash payment and the Reporting person received the remaining 69,030 shares.

F2 · balance_after: On February 25, 2019, the Issuer's Board of Directors approved a grant to the Reporting Person, of a ten-year option to purchase 78,000 shares of the Issuer's common stock at $2.30 per share under the 2011 Amended and Restated Equity Incentive Plan ("2011 Plan"), which vested in full on February 25, 2022. On December 13, 2022, the Reporting Person exercised his option to purchase these shares at an aggregate exercise price of $179,400. The purchase price was paid through a cashless transaction whereby the Issuer withheld 8,970 of the shares at the fair market value of $20 per share, in lieu of cash payment and the Reporting person received the remaining 69,030 shares.

SEC source: 0001062993-23-008120 · form4.xml · nonDerivative · entry 1

Macdonald Sean · CIK 0001553633 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 208,779

F1 · kind: On August 24, 2017, the Issuer's Board of Directors approved a grant to the Reporting Person, of a ten-year option to purchase 78,000 shares of the Issuer's common stock at $1.60 per share under the 2011 Plan, which vested in full on December 31, 2019. On December 13, 2022, the Reporting Person exercised his option to purchase 22,000 of these shares at an aggregate exercise price of $35,200. The purchase price was paid through a cashless transaction whereby the Issuer withheld 1,760 of the shares at the fair market value of $20 per share, in lieu of cash payment and the Reporting person received the remaining 20,240 shares.

F1 · shares: On August 24, 2017, the Issuer's Board of Directors approved a grant to the Reporting Person, of a ten-year option to purchase 78,000 shares of the Issuer's common stock at $1.60 per share under the 2011 Plan, which vested in full on December 31, 2019. On December 13, 2022, the Reporting Person exercised his option to purchase 22,000 of these shares at an aggregate exercise price of $35,200. The purchase price was paid through a cashless transaction whereby the Issuer withheld 1,760 of the shares at the fair market value of $20 per share, in lieu of cash payment and the Reporting person received the remaining 20,240 shares.

F1 · balance_after: On August 24, 2017, the Issuer's Board of Directors approved a grant to the Reporting Person, of a ten-year option to purchase 78,000 shares of the Issuer's common stock at $1.60 per share under the 2011 Plan, which vested in full on December 31, 2019. On December 13, 2022, the Reporting Person exercised his option to purchase 22,000 of these shares at an aggregate exercise price of $35,200. The purchase price was paid through a cashless transaction whereby the Issuer withheld 1,760 of the shares at the fair market value of $20 per share, in lieu of cash payment and the Reporting person received the remaining 20,240 shares.

SEC source: 0001062993-22-016612 · form4.xml · nonDerivative · entry 1

Macdonald Sean · CIK 0001553633 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 188,539

F1 · kind: Represents the private sale of restricted common stock of the Issuer pursuant to a stock purchase agreement, dated July 20, 2022, between the Reporting Person and Astoria Investments Ltd., a Mauritius investment company, and subject to the timing, volume and manner restrictions of Rule 144 of the United States of America Securities Act of 1933. Prior to the reporting date, the Reporting Person held a total of 198,539 shares of the Issuer's common stock. As a result of the transaction, the Reporting Person now holds 188,539 shares of the Issuer's common stock.

F1 · ownership.direct: Represents the private sale of restricted common stock of the Issuer pursuant to a stock purchase agreement, dated July 20, 2022, between the Reporting Person and Astoria Investments Ltd., a Mauritius investment company, and subject to the timing, volume and manner restrictions of Rule 144 of the United States of America Securities Act of 1933. Prior to the reporting date, the Reporting Person held a total of 198,539 shares of the Issuer's common stock. As a result of the transaction, the Reporting Person now holds 188,539 shares of the Issuer's common stock.

SEC source: 0001062993-22-001045 · form4.xml · nonDerivative · entry 3

Macdonald Sean · CIK 0001553633 · Director · CEO and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 198,539

F3 · kind: On December 22, 2021, the Issue's Board approved the award of 12,500 restricted shares of the Issuer's common stock to the Reporting Person, pursuant to a Restricted Stock Award Agreement, under the Issuer's 2011 Plan. Sixty percent, or 7,500 shares, of the restricted stock vested on December 31, 2021, and the remaining forty percent, or 5,000 shares, will vest on four equal parts on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022, respectively; provided, however, that any unvested restricted stock will fully vest in the event of any change in control of the Issuer.

F3 · shares: On December 22, 2021, the Issue's Board approved the award of 12,500 restricted shares of the Issuer's common stock to the Reporting Person, pursuant to a Restricted Stock Award Agreement, under the Issuer's 2011 Plan. Sixty percent, or 7,500 shares, of the restricted stock vested on December 31, 2021, and the remaining forty percent, or 5,000 shares, will vest on four equal parts on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022, respectively; provided, however, that any unvested restricted stock will fully vest in the event of any change in control of the Issuer.

F3 · balance_after: On December 22, 2021, the Issue's Board approved the award of 12,500 restricted shares of the Issuer's common stock to the Reporting Person, pursuant to a Restricted Stock Award Agreement, under the Issuer's 2011 Plan. Sixty percent, or 7,500 shares, of the restricted stock vested on December 31, 2021, and the remaining forty percent, or 5,000 shares, will vest on four equal parts on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022, respectively; provided, however, that any unvested restricted stock will fully vest in the event of any change in control of the Issuer.

F4 · balance_after: Total shares of common stock includes 60,901 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date.

SEC source: 0001062993-22-001045 · form4.xml · nonDerivative · entry 2

Macdonald Sean · CIK 0001553633 · Director · CEO and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 186,039

F2 · kind: On March 29, 2016, the Issuer's Board of Directors approved a grant to the Reporting Person, of a ten-year option to purchase 78,000 shares of the Issuer's common stock at $2.60 per share under the Issuer's 2011 Plan, which vested in full on December 31, 2019. On November 16, 2021, the Reporting Person exercised his option to purchase all 78,000 shares at an aggregate exercise price of $202,800. The purchase price was paid through a cashless transaction whereby the Issuer withheld 6,146 of the shares at the fair market value of $33 per share, in lieu of cash payment and the Reporting person received the remaining 71,854 shares.

F2 · shares: On March 29, 2016, the Issuer's Board of Directors approved a grant to the Reporting Person, of a ten-year option to purchase 78,000 shares of the Issuer's common stock at $2.60 per share under the Issuer's 2011 Plan, which vested in full on December 31, 2019. On November 16, 2021, the Reporting Person exercised his option to purchase all 78,000 shares at an aggregate exercise price of $202,800. The purchase price was paid through a cashless transaction whereby the Issuer withheld 6,146 of the shares at the fair market value of $33 per share, in lieu of cash payment and the Reporting person received the remaining 71,854 shares.

F2 · balance_after: On March 29, 2016, the Issuer's Board of Directors approved a grant to the Reporting Person, of a ten-year option to purchase 78,000 shares of the Issuer's common stock at $2.60 per share under the Issuer's 2011 Plan, which vested in full on December 31, 2019. On November 16, 2021, the Reporting Person exercised his option to purchase all 78,000 shares at an aggregate exercise price of $202,800. The purchase price was paid through a cashless transaction whereby the Issuer withheld 6,146 of the shares at the fair market value of $33 per share, in lieu of cash payment and the Reporting person received the remaining 71,854 shares.

F4 · balance_after: Total shares of common stock includes 60,901 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date.

SEC source: 0001062993-22-001045 · form4.xml · nonDerivative · entry 1

Macdonald Sean · CIK 0001553633 · Director · CEO and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,755

F1 · kind: On August 24, 2017, the Issuer's Board of Directors approved a grant to the Reporting Person, of a ten-year option to purchase 78,000 shares of the Issuer's common stock at $1.60 per share under the 2011 Amended and Restated Equity Incentive Plan ("2011 Plan"), which vested in full on March 29, 2019. On November 16, 2021, the Reporting Person exercised his option to purchase 56,000 of these shares at an aggregate exercise price of $89,600. The purchase price was paid through a cashless transaction whereby the Issuer withheld 2,716 of the shares at the fair market value of $33 per share, in lieu of cash payment and the Reporting person received the remaining 53,284 shares.

F1 · shares: On August 24, 2017, the Issuer's Board of Directors approved a grant to the Reporting Person, of a ten-year option to purchase 78,000 shares of the Issuer's common stock at $1.60 per share under the 2011 Amended and Restated Equity Incentive Plan ("2011 Plan"), which vested in full on March 29, 2019. On November 16, 2021, the Reporting Person exercised his option to purchase 56,000 of these shares at an aggregate exercise price of $89,600. The purchase price was paid through a cashless transaction whereby the Issuer withheld 2,716 of the shares at the fair market value of $33 per share, in lieu of cash payment and the Reporting person received the remaining 53,284 shares.

F1 · balance_after: On August 24, 2017, the Issuer's Board of Directors approved a grant to the Reporting Person, of a ten-year option to purchase 78,000 shares of the Issuer's common stock at $1.60 per share under the 2011 Amended and Restated Equity Incentive Plan ("2011 Plan"), which vested in full on March 29, 2019. On November 16, 2021, the Reporting Person exercised his option to purchase 56,000 of these shares at an aggregate exercise price of $89,600. The purchase price was paid through a cashless transaction whereby the Issuer withheld 2,716 of the shares at the fair market value of $33 per share, in lieu of cash payment and the Reporting person received the remaining 53,284 shares.

F4 · balance_after: Total shares of common stock includes 60,901 shares of the Issuer's common stock directly held by the Reporting Person prior to the reporting date.

SEC source: 0001062993-21-004179 · form4.xml · nonDerivative · entry 1

Macdonald Sean · CIK 0001553633 · Director · CEO and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,901

F1 · kind: On December 29, 2020, the Issuer's Board approved the award of 11,800 restricted shares of the Issuer's common stock to the Reporting Person, pursuant to a Restricted Stock Award Agreement, under the Issuer's 2011 Plan. Sixty percent, or 7,080 shares, of the restricted stock vested immediately, on the date of the award, and the remaining 40%, or 4,720 shares, will vest on two equal parts on December 29, 2021 and 2022, respectively, so long as the Reporting Person is fully employed by the Issuer on such vesting date; provided, however, that any unvested restricted stock will fully vest in the event of any change in control of the Issuer.

F1 · shares: On December 29, 2020, the Issuer's Board approved the award of 11,800 restricted shares of the Issuer's common stock to the Reporting Person, pursuant to a Restricted Stock Award Agreement, under the Issuer's 2011 Plan. Sixty percent, or 7,080 shares, of the restricted stock vested immediately, on the date of the award, and the remaining 40%, or 4,720 shares, will vest on two equal parts on December 29, 2021 and 2022, respectively, so long as the Reporting Person is fully employed by the Issuer on such vesting date; provided, however, that any unvested restricted stock will fully vest in the event of any change in control of the Issuer.

F1 · balance_after: On December 29, 2020, the Issuer's Board approved the award of 11,800 restricted shares of the Issuer's common stock to the Reporting Person, pursuant to a Restricted Stock Award Agreement, under the Issuer's 2011 Plan. Sixty percent, or 7,080 shares, of the restricted stock vested immediately, on the date of the award, and the remaining 40%, or 4,720 shares, will vest on two equal parts on December 29, 2021 and 2022, respectively, so long as the Reporting Person is fully employed by the Issuer on such vesting date; provided, however, that any unvested restricted stock will fully vest in the event of any change in control of the Issuer.

F2 · balance_after: Total common stock includes 49,101 shares of the Issuer's common stock held directly by the Reporting Person as at the transaction date.

SEC source: 0001062993-19-001974 · form4.xml · derivative · entry 1

Macdonald Sean · CIK 0001553633 · Director · CEO and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 234,000

Underlying: Common Stock, par value $0.001 per share · 78,000 shares

Expires 2029-02-24

F1 · kind: The Reporting Person was the holder of vested and unvested options to purchase 156,000 shares of the Issuer's commons stock. On February 25, 2019, the Reporting Person was granted options to purchase another 78,000 shares of the Issuer's common stock at $2.30 per share under the Issuer's 2012 Plan which will expire on February 24, 2029. Options to purchase 30% or 23,400 shares immediately vested, options to purchase another 40% or 31,200 shares will vest in two equal portions of 15,600 each on February 25, 2020 and 2021, respectively, and the remaining 30% or 23,400 shares will vest on February 25, 2022.

F1 · shares: The Reporting Person was the holder of vested and unvested options to purchase 156,000 shares of the Issuer's commons stock. On February 25, 2019, the Reporting Person was granted options to purchase another 78,000 shares of the Issuer's common stock at $2.30 per share under the Issuer's 2012 Plan which will expire on February 24, 2029. Options to purchase 30% or 23,400 shares immediately vested, options to purchase another 40% or 31,200 shares will vest in two equal portions of 15,600 each on February 25, 2020 and 2021, respectively, and the remaining 30% or 23,400 shares will vest on February 25, 2022.

F1 · derivative.exercise_date: The Reporting Person was the holder of vested and unvested options to purchase 156,000 shares of the Issuer's commons stock. On February 25, 2019, the Reporting Person was granted options to purchase another 78,000 shares of the Issuer's common stock at $2.30 per share under the Issuer's 2012 Plan which will expire on February 24, 2029. Options to purchase 30% or 23,400 shares immediately vested, options to purchase another 40% or 31,200 shares will vest in two equal portions of 15,600 each on February 25, 2020 and 2021, respectively, and the remaining 30% or 23,400 shares will vest on February 25, 2022.

F1 · derivative.underlying_shares: The Reporting Person was the holder of vested and unvested options to purchase 156,000 shares of the Issuer's commons stock. On February 25, 2019, the Reporting Person was granted options to purchase another 78,000 shares of the Issuer's common stock at $2.30 per share under the Issuer's 2012 Plan which will expire on February 24, 2029. Options to purchase 30% or 23,400 shares immediately vested, options to purchase another 40% or 31,200 shares will vest in two equal portions of 15,600 each on February 25, 2020 and 2021, respectively, and the remaining 30% or 23,400 shares will vest on February 25, 2022.

SEC source: 0001062993-17-004465 · form4.xml · derivative · entry 4

Macdonald Sean · CIK 0001553633 · Director · CEO and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,000

Underlying: Common Stock, par value $0.001 per share · 78,000 shares

Expires 2027-08-23

F3 · shares: On August 24, 2017, the Issuer's Board of Directors approved a grant to the Reporting Person of another 10-year option to purchase 78,000 shares of the Issuer's common stock at an exercise price of $1.60 a share under the Issuer's 2011 Plan, 31,200 of the options will vest on December 31, 2017 and the remaining options to purchase 46,800 shares will vest in equal portions on December 31, 2018 and 2019, respectively.

F3 · derivative.underlying_shares: On August 24, 2017, the Issuer's Board of Directors approved a grant to the Reporting Person of another 10-year option to purchase 78,000 shares of the Issuer's common stock at an exercise price of $1.60 a share under the Issuer's 2011 Plan, 31,200 of the options will vest on December 31, 2017 and the remaining options to purchase 46,800 shares will vest in equal portions on December 31, 2018 and 2019, respectively.

F2 · balance_after: On March 29, 2016, the Issuer's Board of Directors approved a grant to the Reporting Person of a 10-year option to purchase another 78,000 shares of the Issuer's common stock at an exercise price of $2.60 a share under the Issuer's 2011 Plan, 23,400 of which immediately vested and another 23,400 of which vested on March 29, 2017. The remaining options to purchase 31,200 shares are scheduled to vest in equal parts on March 29, 2018 and 2019, respectively.

F3 · balance_after: On August 24, 2017, the Issuer's Board of Directors approved a grant to the Reporting Person of another 10-year option to purchase 78,000 shares of the Issuer's common stock at an exercise price of $1.60 a share under the Issuer's 2011 Plan, 31,200 of the options will vest on December 31, 2017 and the remaining options to purchase 46,800 shares will vest in equal portions on December 31, 2018 and 2019, respectively.

SEC source: 0001062993-17-004465 · form4.xml · derivative · entry 3

Macdonald Sean · CIK 0001553633 · Director · CEO and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,000

Underlying: Common Stock, par value $0.001 per share · 46,800 shares

Expires 2017-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: On February 1, 2012, the Issuer's Board of Directors approved a grant to the Reporting Person, of a 5-year option to purchase 1,950,000 shares of the Issuer's common stock at $0.04 per share under the Issuer's 2011 Plan. After giving effect to the Reverse Split, the Reporting Person had vested options to purchase 78,000 shares of the Company's common stock at $1.00 per share. On September 1, 2016, the Reporting Person exercised his option to purchase all 78,000 shares at an aggregate exercise price of $78,000. The purchase price was paid through a cashless transaction whereby the Issuer withheld 31,200 of the shares in lieu of cash payment and the Reporting person received the remaining 46,800 shares.

F1 · shares: On February 1, 2012, the Issuer's Board of Directors approved a grant to the Reporting Person, of a 5-year option to purchase 1,950,000 shares of the Issuer's common stock at $0.04 per share under the Issuer's 2011 Plan. After giving effect to the Reverse Split, the Reporting Person had vested options to purchase 78,000 shares of the Company's common stock at $1.00 per share. On September 1, 2016, the Reporting Person exercised his option to purchase all 78,000 shares at an aggregate exercise price of $78,000. The purchase price was paid through a cashless transaction whereby the Issuer withheld 31,200 of the shares in lieu of cash payment and the Reporting person received the remaining 46,800 shares.

F1 · derivative.underlying_shares: On February 1, 2012, the Issuer's Board of Directors approved a grant to the Reporting Person, of a 5-year option to purchase 1,950,000 shares of the Issuer's common stock at $0.04 per share under the Issuer's 2011 Plan. After giving effect to the Reverse Split, the Reporting Person had vested options to purchase 78,000 shares of the Company's common stock at $1.00 per share. On September 1, 2016, the Reporting Person exercised his option to purchase all 78,000 shares at an aggregate exercise price of $78,000. The purchase price was paid through a cashless transaction whereby the Issuer withheld 31,200 of the shares in lieu of cash payment and the Reporting person received the remaining 46,800 shares.

F2 · balance_after: On March 29, 2016, the Issuer's Board of Directors approved a grant to the Reporting Person of a 10-year option to purchase another 78,000 shares of the Issuer's common stock at an exercise price of $2.60 a share under the Issuer's 2011 Plan, 23,400 of which immediately vested and another 23,400 of which vested on March 29, 2017. The remaining options to purchase 31,200 shares are scheduled to vest in equal parts on March 29, 2018 and 2019, respectively.

SEC source: 0001062993-17-004465 · form4.xml · nonDerivative · entry 1

Macdonald Sean · CIK 0001553633 · Director · CEO and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,800

F1 · kind: On February 1, 2012, the Issuer's Board of Directors approved a grant to the Reporting Person, of a 5-year option to purchase 1,950,000 shares of the Issuer's common stock at $0.04 per share under the Issuer's 2011 Plan. After giving effect to the Reverse Split, the Reporting Person had vested options to purchase 78,000 shares of the Company's common stock at $1.00 per share. On September 1, 2016, the Reporting Person exercised his option to purchase all 78,000 shares at an aggregate exercise price of $78,000. The purchase price was paid through a cashless transaction whereby the Issuer withheld 31,200 of the shares in lieu of cash payment and the Reporting person received the remaining 46,800 shares.

F1 · shares: On February 1, 2012, the Issuer's Board of Directors approved a grant to the Reporting Person, of a 5-year option to purchase 1,950,000 shares of the Issuer's common stock at $0.04 per share under the Issuer's 2011 Plan. After giving effect to the Reverse Split, the Reporting Person had vested options to purchase 78,000 shares of the Company's common stock at $1.00 per share. On September 1, 2016, the Reporting Person exercised his option to purchase all 78,000 shares at an aggregate exercise price of $78,000. The purchase price was paid through a cashless transaction whereby the Issuer withheld 31,200 of the shares in lieu of cash payment and the Reporting person received the remaining 46,800 shares.

F1 · price: On February 1, 2012, the Issuer's Board of Directors approved a grant to the Reporting Person, of a 5-year option to purchase 1,950,000 shares of the Issuer's common stock at $0.04 per share under the Issuer's 2011 Plan. After giving effect to the Reverse Split, the Reporting Person had vested options to purchase 78,000 shares of the Company's common stock at $1.00 per share. On September 1, 2016, the Reporting Person exercised his option to purchase all 78,000 shares at an aggregate exercise price of $78,000. The purchase price was paid through a cashless transaction whereby the Issuer withheld 31,200 of the shares in lieu of cash payment and the Reporting person received the remaining 46,800 shares.

SEC source: 0001062993-17-004465 · form4.xml · derivative · entry 2

Macdonald Sean · CIK 0001553633 · Director · CEO and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,000

Underlying: Common Stock, par value $0.001 per share · 78,000 shares

Expires 2026-03-28

F2 · shares: On March 29, 2016, the Issuer's Board of Directors approved a grant to the Reporting Person of a 10-year option to purchase another 78,000 shares of the Issuer's common stock at an exercise price of $2.60 a share under the Issuer's 2011 Plan, 23,400 of which immediately vested and another 23,400 of which vested on March 29, 2017. The remaining options to purchase 31,200 shares are scheduled to vest in equal parts on March 29, 2018 and 2019, respectively.

F2 · derivative.exercise_date: On March 29, 2016, the Issuer's Board of Directors approved a grant to the Reporting Person of a 10-year option to purchase another 78,000 shares of the Issuer's common stock at an exercise price of $2.60 a share under the Issuer's 2011 Plan, 23,400 of which immediately vested and another 23,400 of which vested on March 29, 2017. The remaining options to purchase 31,200 shares are scheduled to vest in equal parts on March 29, 2018 and 2019, respectively.

F2 · derivative.underlying_shares: On March 29, 2016, the Issuer's Board of Directors approved a grant to the Reporting Person of a 10-year option to purchase another 78,000 shares of the Issuer's common stock at an exercise price of $2.60 a share under the Issuer's 2011 Plan, 23,400 of which immediately vested and another 23,400 of which vested on March 29, 2017. The remaining options to purchase 31,200 shares are scheduled to vest in equal parts on March 29, 2018 and 2019, respectively.

F1 · balance_after: On February 1, 2012, the Issuer's Board of Directors approved a grant to the Reporting Person, of a 5-year option to purchase 1,950,000 shares of the Issuer's common stock at $0.04 per share under the Issuer's 2011 Plan. After giving effect to the Reverse Split, the Reporting Person had vested options to purchase 78,000 shares of the Company's common stock at $1.00 per share. On September 1, 2016, the Reporting Person exercised his option to purchase all 78,000 shares at an aggregate exercise price of $78,000. The purchase price was paid through a cashless transaction whereby the Issuer withheld 31,200 of the shares in lieu of cash payment and the Reporting person received the remaining 46,800 shares.

F2 · balance_after: On March 29, 2016, the Issuer's Board of Directors approved a grant to the Reporting Person of a 10-year option to purchase another 78,000 shares of the Issuer's common stock at an exercise price of $2.60 a share under the Issuer's 2011 Plan, 23,400 of which immediately vested and another 23,400 of which vested on March 29, 2017. The remaining options to purchase 31,200 shares are scheduled to vest in equal parts on March 29, 2018 and 2019, respectively.